FDA Import Refusal 799-6241705-2/71/2 — Glaxo India

Glaxo India — FEI 3000146207

The FDA refused shipment 799-6241705-2/71/2 from Glaxo India (India) on March 14, 2025. The refused product falls under Drugs and Biologics — CLAVULANATE POTASS./TICARCILLIN DISODIUM (INHIBITOR (DECARBOXYLASE)). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 14, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
64UDA05 CLAVULANATE POTASS./TICARCILLIN DISODIUM (INHIBITOR (DECARBOXYLASE))
Charges
75